Biological Clock: How Female Fertility Declines With Age (Part 2) - Enhancing Fertility and Combating Ovarian Aging

Author: BalanceGenics Longevity Research Team (How100.com)

Enhancing Fertility and Combating Ovarian Aging: Lifestyle Strategies and Promising Pharmaceuticals

Table of Contents:

1. Six Healthy Lifestyle Tips to Support Ovarian Health
   • Avoid Smoking
   • Limit Alcohol Consumption
   • Adopt a Healthy Diet
   • Maintain a Healthy Weight
   • Engage in Regular Exercise
   • Consider Medical Interventions
2. Promising Pharmaceuticals for Combating Female Reproductive Aging
   • Antioxidants
   • Hormones
   • Mitochondrial Boosters
   • Glucose Metabolism Regulators
   • Other Promising Compounds: α-Ketoglutarate (AKG) and Rapamycin

Six Healthy Lifestyle Tips to Support Ovarian Health

1. Avoid Smoking

Smoking is not only detrimental to overall health but also has negative effects on reproductive outcomes. It is associated with poorer IVF results, pregnancy complications, and early menopause. Most clinical studies show a dose-response relationship between smoking and the risk of early menopause. Quitting smoking can help protect ovarian function and preserve reproductive health.

2. Limit Alcohol Consumption

Even moderate alcohol consumption (3 to 13 drinks per week) can accelerate ovarian aging and reduce fertility. While some studies differ, the majority support the notion that limiting alcohol intake improves reproductive outcomes and overall health, particularly if you plan on becoming pregnant.

3. Adopt a Healthy Diet

A balanced diet rich in whole grains, lean proteins, healthy fats, fruits, and vegetables supports ovarian and overall health. Foods high in antioxidants, such as berries and nuts, help combat oxidative stress. Soy products containing phytoestrogens offer protective benefits for the female reproductive system. However, excessive soy intake (>100 mg soy isoflavones/day) may disrupt hormonal cycles. Consuming soy in moderation, akin to typical Asian diets (10-25 mg isoflavones/day), can provide benefits without risks. It's important not to confuse soy with other legumes.

4. Maintain a Healthy Weight

Both obesity and being underweight can disrupt hormonal balance and ovulation. Obesity, in particular, is linked to a reduced likelihood of live births post-IVF and altered levels of anti-Mullerian hormone (AMH), an ovarian reserve marker. Maintaining a healthy weight through a balanced diet and regular exercise is crucial for reproductive health. Consult a healthcare professional for personalized weight management advice.

5. Engage in Regular Exercise

Consistent physical activity, including aerobic exercises, strength training, and flexibility exercises, enhances overall health and positively impacts ovarian reserve. While the benefits of moderate exercise for ovarian health are well-documented, the impact of intense exercise remains controversial. Nonetheless, female athletes generally have ovarian reserve levels comparable to the general population.

6. Consider Medical Interventions

Age is a significant factor in the success of assisted reproductive technologies (ART). If pregnancy is delayed, proactive planning and exploring fertility preservation options (such as egg or embryo freezing) may be advantageous. Typically, IVF is recommended if a couple fails to conceive after one year of trying. Hormone replacement therapy (HRT) can help manage menopausal symptoms but should be used under medical supervision, generally for less than five years to minimize risks.

Promising Pharmaceuticals for Combating Female Reproductive Aging

1. Antioxidants

Oxidative stress, primarily caused by reactive oxygen species (ROS), contributes to ovarian aging. Compounds with antioxidant properties, such as vitamins C and E, coenzyme Q10 (CoQ10), N-acetyl-L-cysteine (NAC), and certain flavonoids, have shown potential in rodent models to improve ovarian reserve, follicle health, and reproductive outcomes. However, antioxidant supplementation in pharmacological doses has been linked to adverse effects, including disruption of ovarian and uterine function. Limited clinical research in women undergoing ART due to age-related infertility has yielded inconsistent results. Some studies have even reported decreased pregnancy rates with certain antioxidant supplements like resveratrol. Further optimization of dosage and treatment duration is needed to ensure safe and effective use.

2. Hormones

DHEA and Isoflavones
Beyond directly addressing hormone deficiencies caused by ovarian aging with estrogen and progesterone, other hormones have been explored. DHEA, a precursor to estrogen, and isoflavones, plant estrogens with antioxidant properties, are notable examples. Clinical studies suggest DHEA supplementation over 2-3 months may enhance egg and embryo quality, particularly for women with diminished ovarian reserve or advanced age. However, while some studies report improvements, most have not found significant increases in pregnancy rates, and comprehensive health assessments of participants are often lacking. Larger randomized controlled trials are necessary to determine the true efficacy of DHEA. Isoflavones interact with estrogen receptors similarly to estradiol. In rodent studies, isoflavones have been shown to slow follicular development, enhancing ovarian reserve and maintaining ovulation cycles. However, conclusive pregnancy outcome data is still needed.

Melatonin
Known for its sleep-promoting and antioxidant properties, melatonin has shown promise in extending reproductive lifespan and/or improving ovarian markers in both animal and clinical studies. While positive effects on egg quality and quantity have been observed in rodents, clinical studies in women with infertility or IVF failures have yielded mixed results. The widespread metabolic and physiological effects of melatonin complicate its translation to clinical use due to concerns about unexpected adverse reactions over long-term use.

3. Mitochondrial Boosters

Mitochondrial dysfunction is a hallmark of aging and has been linked to ovarian aging and infertility. Many potential longevity drugs exhibit protective effects on mitochondria, and mitochondrial content is an important marker of egg quality. In addition to previously mentioned antioxidant treatments (e.g., coenzyme Q10, vitamins C and E, and flavonoids), novel methods to boost nicotinamide adenine dinucleotide (NAD+) have shown promising results. Recent studies on NAD+ supplementation using compounds like nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN) in young and middle-aged mice have demonstrated significant rejuvenation of eggs, promoting fertility. This rejuvenation is attributed to reduced ROS levels and improved ovarian mitochondrial metabolism.

Future focus on mitochondrial enhancers is expected to increase, given the growing evidence linking mitochondrial dysfunction to female reproductive aging, particularly involving NADH/NAD+ redox balance disruption.

4. Glucose Metabolism Regulators

Research into glucose metabolism regulators, particularly metformin, has gained significant attention in longevity studies. Initially focused on its use in polycystic ovary syndrome (PCOS), recent studies in normal mice indicate metformin's potential to combat age-related ovarian fibrosis, improve follicle numbers, and establish regular ovulation cycles. Metformin has also shown protective effects on ovarian follicles in female rodents facing infertility challenges induced by non-aging factors like chemotherapy. However, some studies have shown inconsistent results, highlighting the need for further research to fully evaluate metformin's impact on ovarian function.

5. Other Promising Compounds: α-Ketoglutarate (AKG) and Rapamycin

α-Ketoglutarate (AKG) and rapamycin have shown promising effects on ovarian longevity in rodent models. AKG, a key component of the Krebs cycle, enhances protein synthesis, supports bone growth, and improves antioxidant systems. AKG's anti-apoptotic and antioxidant properties have been found to improve egg quality in pigs. Additionally, long-term AKG use maintains ovarian function and fertility in aging mice while reducing telomere shortening.

Rapamycin, known for its potential in delaying ovarian aging, inhibits a key cellular pathway (mTOR) involved in follicle development and ovarian aging. mTOR inhibition has been linked to increased primordial follicle numbers and extended reproductive lifespan in rodents. Recent studies suggest that short-term rapamycin treatment can improve fertility and ovarian lifespan without disrupting ovulation cycles.

Conclusion

By understanding and implementing strategies to support ovarian health and exploring promising pharmaceutical interventions, women can better manage reproductive aging and enhance overall well-being. While current research offers hopeful prospects, further studies are necessary to translate these findings into effective clinical applications.

BalanceGenics:  Personalized One-Stop Longevity Platform (How100.com)

Launched in California in 2018, BalanceGenics ("How100") started out as a solution to our own needs. Our team consists of seasoned health experts, doctors, and entrepreneurs with a common interest in anti-aging.

We use the latest findings from global leading longevity scientists to develop products and services, focusing on Longevity Supplements (cellular anti-aging) and Physical Therapy Exercises (physical anti-aging).

BalanceGenics' Mission is to  create personalized solutions to live longer but stay younger. 

Build Your Personalized Anti-aging & Longevity Plan.

References

1. Morrison, D. J., & Preston, T. (2016). "The role of gut microbiota in the metabolism of dietary nutrients." Journal of Nutrition and Metabolism.
2. Tang, W. H. W., et al. (2013). "Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis." Nature Medicine, 19(5), 576-585.
3. Schugar, R. C., et al. (2017). "The TMAO hypothesis: A potential risk factor for cardiovascular disease." Frontiers in Cardiovascular Medicine, 4, 1-10.
4. Kumar, A., & Gupta, A. (2020). "Microbiota and cardiovascular disease: A review." Heart Failure Clinics, 16(3), 363-375.
5. Cleveland Clinic. (2017). "High TMAO Levels Linked to Increased Cardiovascular Risk." Cleveland Clinic Newsroom.
6. Wu, H., et al. (2015). "Dietary patterns and cardiovascular disease: A review." Nutrition Reviews, 73(8), 547-558.
7. Zhang, A., et al. (2019). "Gut microbiota and cardiovascular disease: A review." Journal of Cardiovascular Translational Research, 12(3), 235-245.

By understanding these factors and exploring available treatments, women can make informed decisions to better manage reproductive health and aging.